ATE210446T1 - Verwendung von 1,5-benzodiazepinderivaten zur kontrolle des magen entleerens bei nicht insulinabhängigem diabetes mellitus - Google Patents
Verwendung von 1,5-benzodiazepinderivaten zur kontrolle des magen entleerens bei nicht insulinabhängigem diabetes mellitusInfo
- Publication number
- ATE210446T1 ATE210446T1 AT95935280T AT95935280T ATE210446T1 AT E210446 T1 ATE210446 T1 AT E210446T1 AT 95935280 T AT95935280 T AT 95935280T AT 95935280 T AT95935280 T AT 95935280T AT E210446 T1 ATE210446 T1 AT E210446T1
- Authority
- AT
- Austria
- Prior art keywords
- insulin
- diabetes mellitus
- dependent diabetes
- benzodiazepine derivatives
- stomach emptying
- Prior art date
Links
- ZVAPWJGRRUHKGP-UHFFFAOYSA-N 1h-1,5-benzodiazepine Chemical class N1C=CC=NC2=CC=CC=C12 ZVAPWJGRRUHKGP-UHFFFAOYSA-N 0.000 title 1
- 210000002784 stomach Anatomy 0.000 title 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 title 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9420747A GB9420747D0 (en) | 1994-10-14 | 1994-10-14 | 1,5 benzodiazepine derivatives |
| PCT/US1995/012830 WO1996011691A1 (en) | 1994-10-14 | 1995-10-13 | Use of 1,5-benzodiazepine derivatives for the control of gastric emptying in patients with non-insulin dependent diabetes mellitus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE210446T1 true ATE210446T1 (de) | 2001-12-15 |
Family
ID=10762854
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95935280T ATE210446T1 (de) | 1994-10-14 | 1995-10-13 | Verwendung von 1,5-benzodiazepinderivaten zur kontrolle des magen entleerens bei nicht insulinabhängigem diabetes mellitus |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0785787B1 (de) |
| JP (1) | JPH10511931A (de) |
| AT (1) | ATE210446T1 (de) |
| AU (1) | AU3736195A (de) |
| DE (1) | DE69524622T2 (de) |
| DK (1) | DK0785787T3 (de) |
| ES (1) | ES2166406T3 (de) |
| GB (1) | GB9420747D0 (de) |
| PT (1) | PT785787E (de) |
| WO (1) | WO1996011691A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2239293A1 (en) | 1995-12-11 | 1997-06-19 | New England Medical Center Hosptials, Inc. | Assay for and uses of peptide hormone receptor ligands |
| US5750353A (en) * | 1995-12-11 | 1998-05-12 | New England Medical Center Hospitals, Inc. | Assay for non-peptide agonists to peptide hormone receptors |
| AU6124599A (en) * | 1998-10-20 | 2000-05-08 | Takeda Chemical Industries Ltd. | 1,5-benzodiazepine compounds, process for producing the same, and medicine |
| US9815850B2 (en) | 2016-02-05 | 2017-11-14 | Denali Therapeutics Inc. | Compounds, compositions and methods |
| HUE058802T2 (hu) | 2016-12-09 | 2022-09-28 | Denali Therapeutics Inc | RIPK1 inhibitorokként alkalmas vegyületek |
| AU2020363377A1 (en) | 2019-10-07 | 2022-04-21 | Kallyope, Inc. | GPR119 agonists |
| EP4110788A4 (de) | 2020-02-28 | 2024-08-28 | Kallyope, Inc. | Gpr40-agonisten |
| WO2023137035A1 (en) | 2022-01-12 | 2023-07-20 | Denali Therapeutics Inc. | Crystalline forms of (s)-5-benzyl-n-(5-methyl-4-oxo-2, 3,4,5- tetrahydropyrido [3,2-b] [l,4]oxazepin-3-yl)-4h-l,2,4-triazole-3-carboxamide |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5187154A (en) * | 1990-12-13 | 1993-02-16 | Board Of Regents, The University Of Texas System | Diagnosis and treatment of humans with diabetes or at risk to develop diabetes |
| GB9307833D0 (en) * | 1993-04-15 | 1993-06-02 | Glaxo Inc | Modulators of cholecystokinin and gastrin |
-
1994
- 1994-10-14 GB GB9420747A patent/GB9420747D0/en active Pending
-
1995
- 1995-10-13 JP JP8513314A patent/JPH10511931A/ja not_active Ceased
- 1995-10-13 AT AT95935280T patent/ATE210446T1/de active
- 1995-10-13 WO PCT/US1995/012830 patent/WO1996011691A1/en not_active Ceased
- 1995-10-13 AU AU37361/95A patent/AU3736195A/en not_active Abandoned
- 1995-10-13 ES ES95935280T patent/ES2166406T3/es not_active Expired - Lifetime
- 1995-10-13 EP EP95935280A patent/EP0785787B1/de not_active Expired - Lifetime
- 1995-10-13 DE DE69524622T patent/DE69524622T2/de not_active Expired - Lifetime
- 1995-10-13 PT PT95935280T patent/PT785787E/pt unknown
- 1995-10-13 DK DK95935280T patent/DK0785787T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| DE69524622T2 (de) | 2002-08-08 |
| GB9420747D0 (en) | 1994-11-30 |
| JPH10511931A (ja) | 1998-11-17 |
| DE69524622D1 (de) | 2002-01-24 |
| AU3736195A (en) | 1996-05-06 |
| EP0785787A1 (de) | 1997-07-30 |
| WO1996011691A1 (en) | 1996-04-25 |
| PT785787E (pt) | 2002-04-29 |
| EP0785787B1 (de) | 2001-12-12 |
| ES2166406T3 (es) | 2002-04-16 |
| DK0785787T3 (da) | 2002-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG62620B1 (bg) | Карбоциклични съединения | |
| WO1996015784A3 (de) | 2,2-dichloralkancarbonsäuren, verfahren zu ihrer herstellung diese enthaltende arzneimittel, und ihre verwendung zur behandlung der insulinresistenz | |
| NZ516599A (en) | 2-arylimino-2,3-dihydrothiazoles, and their use thereof as somatostatin receptor ligands | |
| ATE210446T1 (de) | Verwendung von 1,5-benzodiazepinderivaten zur kontrolle des magen entleerens bei nicht insulinabhängigem diabetes mellitus | |
| AU601280B2 (en) | Mixed crystals of insulin and insulin derivatives, a process for the preparation of these mixed crystals, pharmaceutical agents containing these mixed crystals, and the use thereof for the treatment of diabetes mellitus | |
| DE69717091D1 (de) | Oxazole derivate,ihre herstellung und verwendung | |
| ATE158795T1 (de) | Thiazolidindionderivate, ihre herstellung und anwendung | |
| EE9700094A (et) | Aminoguanidiinkarboksülaadid insuliinisõltumatu suhkurtõve raviks | |
| MY115466A (en) | Substituted cinnamic acid guanidides, a process for their preparation, their use as medicaments or diagnostic agents and medicaments comprising them. | |
| AU7077096A (en) | Selective beta 3 adrenergic agonists | |
| DE69825981D1 (de) | 4,5-dihydroxy-2-cyclopenten-1-on für die Behandlung von Diabetes Mellitus | |
| KR930701170A (ko) | 항당뇨병약품 | |
| EP1121932A4 (de) | Heilmittel für augenerkrankungen | |
| ES2181923T3 (es) | 4-hidroxicumarin-3-carboxamidas para el tratamiento de la diabet es mellitus no dependiente de la insulina. | |
| ATE101139T1 (de) | (alkylthio-3-propyl)-3-benzothiazolinderivate, ihre herstellung und diese enthaltende arzneimittel. | |
| HU9502663D0 (en) | Bicyclic substituted oxazol- and thiazol-ethers | |
| IL96683A0 (en) | Imidazolyl propyl guanidine derivative,a process for its preparation and a pharmaceutical composition containing this compound | |
| KR880011077A (ko) | 유효치료 물질로서 사용하기 위한 tert- 부틸아미노-3(페닐-2'-펜옥시)-1-프로판올-2 및 그의 산부가염 | |
| DE3864209D1 (de) | Pharmazeutische verwendung aromatischer thioaether. | |
| RU97108937A (ru) | Средство для гидропрепаровки поджелудочной железы при ее резекциях | |
| CA2247419A1 (en) | Oxazole derivatives, their production and use | |
| NO893606L (no) | Behandling av diabetes mellitus type 2. | |
| SI0785787T1 (en) | Use of 1,5-benzodiazepine derivatives for the control of gastric emptying in patients with non-insulin dependent diabetes mellitus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |